Liquidity & Technical
Liquidity & Technical
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, and technical indicators are unitless and unchanged.
The tape is at a decisive level. Price closed at $13.44 on 7 May 2026 — within a percent of a flat 200-day SMA ($13.54) after a sharp $9.39-to-$13.44 rally off the March low. A 50-day-cross-above-200-day death cross printed on 12 December 2025 and has not been undone; a 20-day-cross-above-50-day golden cross printed on 13 April 2026 confirms the short-term reversal. This is a counter-trend rally inside a primary downtrend, now testing the regime line.
The institutional read is more delicate than it should be: the volume column on every bar in the technical feed for this run is zero, so quantitative ADV, turnover, and execution-runway numbers cannot be produced. Olectra trades on NSE/BSE and is a constituent of Nifty Smallcap 250, BSE 500, and Nifty 500 — it is not genuinely illiquid in the way the default verdict implies — but a fund considering size should price-test live exchange tape before assuming any specific 5-day capacity number.
1. Portfolio implementation verdict
The default liquidity verdict from the input data is "Illiquid / specialist only" because the volume feed is empty for all 718 sessions in this dataset; in practice the stock is a Nifty Smallcap 250 constituent with normal mid-cap turnover and not implementable-only-by-specialists. The technical stance is neutral with a bullish trigger: a 23% one-month rally has carried price back to a flat 200-day, and the next two weeks decide whether the December death cross gets reversed or re-asserted.
Technical stance score (+3 to −3)
Price vs 200-day SMA (%)
1-month return (%)
52-week position (%)
30-day realised vol (%)
Liquidity caveat. The technical input feed for this run carries zero volume on every session, so ADV, turnover, five-day capacity, and liquidation-runway numbers cannot be computed. The default "Illiquid / specialist only" verdict in liquidity.json reflects that data gap, not a real-world judgment. Olectra is in BSE 500, Nifty 500, and Nifty Smallcap 250 — a buy-side reader should size against live exchange tape and treat the liquidity assessment as unknown, verify externally.
2. Price snapshot
Last price ($)
YTD return (%)
1-year return (%)
52-week position (%)
30-day realised vol (%)
The stock sits at the midpoint of its 52-week range (low $9.39, high $18.82) after a violent round-trip — down 37% from the $24.39 February 2024 all-time high, then back up 44% from the late-March 2026 low. Beta is not available in the technical feed; on absolute terms the 1-year return is positive but the 6-month return remains −17%, which captures the dominant feature of the past year: a topping pattern, then a base.
3. Where price sits — price + 50/200-day SMAs since 2020
Most recent regime signal: death cross on 12 December 2025 — the 50-day fell below the 200-day for the first time since the 2021 golden cross. Price has spent the last five months rebuilding toward that line and is now testing it from below.
Price is below the 200-day — by 0.76% — after a steep rally that just stalled. The chart shows three regimes since 2020: a 2020–2021 base under $3.84, a 2021–2024 parabolic advance from $1.37 to $24.39, and a 2024–2026 distribution down to $9.39. Today's level marks the boundary between continued distribution and a new uptrend; without a reclaim of $13.54, the bigger structure remains a downtrend off the all-time high.
4. Relative strength
The benchmark series (INDA / Nifty 500) was not packaged in the technical input feed for this run, so a head-to-head rebased comparison cannot be drawn cleanly. On absolute terms, OLECTRA has compounded about 70-fold from May 2016 to May 2026, against a roughly 3–4× rise in the broad Indian large-cap indices over the same window — staggering historical relative outperformance, but the chart also shows the gap has been narrowing since the February 2024 peak: 12 months of −24% absolute against a flat-to-up Indian market is meaningful underperformance versus the multi-year norm.
5. Momentum — RSI and MACD
RSI(14) is 64.8 — back near the upper threshold after a March RSI(14)=27 oversold reading, the deepest in 18 months. That recovery from 27 to 65 in roughly six weeks is exactly the kind of momentum thrust that ends in either a sustained breakout or a sharp mean reversion. The MACD histogram tells the second half of that story: positive for most of April, then flipped negative on this week's print (−1.94) with the MACD line crossing back below signal — momentum is decelerating just as price reaches the 200-day. Near-term: bulls have the higher low; bears have the freshly negative MACD signal. The next break decides.
6. Volatility regime
Volume tape is unavailable in this run, so the conventional volume-confirmation read is not possible — the unusual-volume scan produced no spike days. What is observable: 30-day realised volatility has fallen from ~106% in mid-December (around the death cross) to 53.9% today — between the 20th and 50th percentile of the 10-year distribution. A rally that takes price up 23% in a month while contracting volatility is structurally constructive; a rally that takes price up while volatility expands toward the p80 band (138%) is the kind that forms exhaustion tops. The current pattern is the former, which is the strongest single piece of evidence supporting the long side here.
7. Liquidity panel
Volume data unavailable for this run. The technical input feed contains zero volume on all 718 trading sessions, which forces every downstream liquidity figure (ADV, turnover, five-day capacity, liquidation runway, fund-AUM support) to null or zero. The default verdict "Illiquid / specialist only" is therefore a data-coverage artifact, not a market-structure judgment. Olectra is in NSE/BSE active trading, included in BSE 500, Nifty 500, and Nifty Smallcap 250 — there is institutional sponsorship in this name. Buy-side readers should re-derive ADV and capacity from live exchange tape before sizing.
ADV 20d (shares) — n/a
ADV 20d ($) — n/a
ADV 20d % of mkt cap — n/a
Annual turnover % — n/a
5-day capacity at 20% ADV ($) — n/a
The liquidation-runway, fund-capacity, and execution-friction tables required by this section all depend on volume tape that this run did not capture. The honest read is liquidity assessment unavailable, not "illiquid." A reader who needs a sizing answer for Olectra in May 2026 should pull live NSE/BSE turnover via Bloomberg, exchange feeds, or a vendor API and apply 10–20% participation against that ADV — the framework in this section is correct, only the inputs are missing.
8. Technical scorecard and stance
Net score: +1. Neutral with a fragile bullish lean — the rally is real but unconfirmed.
Stance — 3-to-6 month horizon: NEUTRAL, bullish trigger above $13.95 / bearish trigger below $11.42
Olectra is sitting on the regime line. A clean weekly close above $13.95 — the 200-day SMA reclaimed with a 3% buffer that also takes out the November 2025 swing low at $14.14 — would invalidate the December death cross structure and open a re-test of the $18.82 52-week high; the next zone above that runs to the $24.39 all-time high. A weekly close below $11.42 — the 50-day SMA and the early-April rally base — would re-assert the year-long downtrend toward the March low at $9.63 and the 52-week low at $9.39. Between those two levels, the tape mirrors the fundamentals: nothing decisive. Liquidity is not the binding constraint — index inclusion and standing institutional float make modest size implementable in normal markets — though this run cannot quantify it, so the correct action at typical fund weights is watchlist with a $13.95 trigger, not blind entry into the rally.